Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 60 , Issue 13
Showing 1-34 articles out of 34 articles from the selected issue
EDITORIAL
ORIGINAL ARTICLES
  • Shinya Sugimoto, Aiji Hattori, Yuri Maegawa, Haruka Nakamura, Naoko Ok ...
    2021 Volume 60 Issue 13 Pages 1989-1997
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    Objective The safety and prognosis of complete stone removal for the treatment of choledocholithiasis in older patients are unknown. This multicenter retrospective study assessed the outcomes of complete stone removal in elderly patients (≥90 years) with respect to the prognosis.

    Methods We divided patients who underwent endoscopic cholangiopancreatography for choledocholithiasis into two groups: complete stone removal or incomplete stone removal with plastic stent insertion. The patient characteristics, adverse events, number of endoscopic cholangiopancreatographies, overall survival rates, and disease-specific cumulative death were compared between the groups.

    Patients Two hundred and twenty-three participants ≥90 years old were included in the study, including 48 (22%) men and 175 (78%) women. The median age was 92 (range, 90-104) years old. There were 160 (72%) and 63 (28%) patients in the complete and incomplete groups, respectively.

    Results The age, performance status, comorbidities, severe complication rates, and stone diameter were comparable between the groups. The proportion of patients with at least 5 stones was significantly higher in the incomplete group than in the complete group [complete group: 8.1% (13/160) and incomplete group: 21% (13/63), p<0.01]. The overall survival rate was significantly higher in the complete group (p<0.01), while the disease-specific cumulative death rate was higher in the incomplete group (p<0.01).

    Conclusion Complete stone removal for choledocholithiasis may contribute to a better prognosis in elderly patients ≥90 years old.

    Download PDF (485K)
  • Keisuke Senda, Takashi Miura, Tamon Kato, Yusuke Kanzaki, Naoyuki Abe, ...
    2021 Volume 60 Issue 13 Pages 1999-2006
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    Objective Despite reports on the effects of ankle-brachial index (ABI) improvement following endovascular therapy (EVT) on the limb prognosis, studies evaluating cardiovascular events are limited. We investigated whether or not ABI improvement 1 year following EVT was associated with cardiovascular events.

    Methods The I-PAD NAGANO registry is an observational multicenter cohort study that enrolled 337 patients with peripheral artery disease (PAD) who underwent EVT between August 2015 and July 2016. From this cohort, we identified 232 patients whose ABI data 1 year following EVT were available, after excluding patients with critical limb ischemia. We divided the patients into two groups according to the degree of ABI improvement 1 year following EVT (ΔABI) - the ΔABI <0.15 group and the ΔABI ≥0.15 group - and compared the outcomes. The primary endpoint was major adverse cardiovascular events (MACEs), including all - cause death, myocardial infarction (MI), and stroke. The secondary endpoints were major adverse limb events (MALEs), defined as a composite of target lesion revascularization and major amputation, all - cause death, MI, and stroke. The median follow-up period was 3.3 years.

    Results The incidence of MACEs was significantly higher in the ΔABI <0.15 group than in the ΔABI ≥0.15 group (ΔABI <0.15 vs. ΔABI ≥0.15, 25.8% vs. 11.9%, log-rank p=0.036), as was the incidence of stroke (14.1% vs. 2.2%, log-rank p=0.016). A Cox regression analysis revealed that ΔABI ≥0.15 was significantly associated with fewer MACEs (hazard ratio 0.38, 95% confidence interval 0.17-0.83, p=0.016).

    Conclusion An increase in ABI ≥0.15 at 1 year following EVT was a predictor of reduced MACEs.

    Download PDF (893K)
  • Naruhiro Yamasaki, Masaru Sakurai, Junji Kobayashi, Yuko Morikawa, Ter ...
    2021 Volume 60 Issue 13 Pages 2007-2015
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    Objective This study investigated associations between three indices of obesity-the body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR)-and the incidence of chronic kidney disease (CKD).

    Methods The employees of a company in Japan (1,725 men, 1,186 women; aged 35-55 years) had BMI, WC, and WHtR measured in health examinations. The incidence of CKD was determined at annual medical examinations over a six-year period. The hazard ratios for CKD were calculated using proportional hazard models, and the χ2 statistic was used to compare the strengths of the associations.

    Results The mean BMI (kg/m2), WC (cm), and WHtR were 23.6, 84.3, and 0.49 for men and 22.3, 79.7, and 0.50 for women, respectively. The incidence of CKD (/1,000 person-years) was 18.1 for men and 8.4 for women. In men, positive linear associations were observed between the BMI, WC, and WHtR and the risk of CKD, even after adjusting for the presence of metabolic abnormalities (p for trend <0.001, 0.012, and 0.023, respectively). In women, a linear association was observed only between the WHtR and CKD, not the BMI or WC (p for trend =0.042, 0.057, and 0.186). The χ2 statistics were the highest for the BMI in both men and women.

    Conclusion The BMI, WC, and WHtR were linearly associated with the risk of CKD independently of metabolic abnormalities in men, while the associations were weaker or not significant in women. The BMI was the most strongly associated with the incidence of CKD in both men and women.

    Download PDF (166K)
  • Jun Ino, Eri Kasama, Mio Kodama, Keitaro Sato, Hitoshi Eizumi, Youichi ...
    2021 Volume 60 Issue 13 Pages 2017-2026
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    Objective Although recent reports have highlighted the benefits of multidisciplinary team care (MTC) for chronic kidney disease (CKD) in slowing the progress of renal insufficiency, its long-term effects have not been evaluated for patients with diabetes mellitus (DM). We compared the renal survival rate between MTC and conservative care (CC).

    Methods In this five-year, single-center, prospective, observational study, we examined 24 patients (mean age 65.5±12.1 years old, men/women 18/6) with DM-induced CKD stage ≥3 in an MTC clinic. The control group included 24 random patients with DM (mean age 61.0±12.8 years old, men/women 22/2) who received CC. MTC was provided by a nephrologist and medical staff, and CC was provided by a nephrologist.

    Results In total, 10 MTC and 20 CC patients experienced renal events [creatinine doubling, initiation of renal replacement therapy (RRT), or death due to end-stage CKD]. During the five-year observation period, there were significantly fewer renal events in the MTC group than in the CC group according to the cumulative incidence method (p=0.006). Compared to CC, MTC significantly reduced the need for urgent initiation of hemodialysis (relative risk reduction 0.79, 95% confidence interval [CI] 0.107-0.964). On a multivariate analysis, MTC (hazard ratio [HR], 0.434, 95% CI 0.200-0.939) and the slope of the estimated glomerular filtration rate during the first year (HR, 0.429 per 1 mL/min/m2/year, 95% CI 0.279-0.661) were negatively associated with renal events.

    Conclusion MTC for DM-induced CKD is an effective strategy for delaying RRT. Long-term MTC can demonstrate reno-protective effects.

    Download PDF (354K)
  • Ryota Dokuni, Kazuyuki Kobayashi, Yoshiharu Ohno, Tatsuya Nagano, Dais ...
    2021 Volume 60 Issue 13 Pages 2027-2032
    Published: July 01, 2021
    Released: July 01, 2021
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective Bronchial thermoplasty (BT) is a bronchoscopic procedure for patients with severe asthma. Although it has been suggested that BT works by reducing airway smooth muscle, the detailed mechanism underlying its effects is still unknown.

    Methods We performed xenon ventilation computed tomography (Xe-CT) before each BT procedure and six weeks after the third treatment to assess the improvement in lung ventilation at each separate lung region. The air trapping index in each lobe was defined as the mean trapping value (0: none, 1: mild, 2: moderate, and 3: severe) of the included segments.

    Patients and Materials Four patients were included.

    Results Asthma symptoms were improved after BT. The comparison of the scores at baseline with those after the third treatment showed that the air trapping index was improved in both the treated and untreated regions. However, neither the pulmonary function nor the exhaled nitric oxide was improved.

    Conclusion Using Xe-CT, we successfully evaluated the air trapping in patients who underwent BT. The improvement in asthma symptoms by BT may be related to the amelioration of peripheral lung ventilation in both the treated and untreated regions.

    Download PDF (453K)
CASE REPORTS
  • Taisuke Obata, Kazuyuki Matsumoto, Hironari Kato, Tatsuhiro Yamazaki, ...
    2021 Volume 60 Issue 13 Pages 2033-2038
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    A 76-year-old woman with branch duct intraductal papillary mucinous neoplasm (IPMN) was admitted with epigastric pain and vomiting. She had received warfarin due to a history of deep vein thrombosis. A blood test showed decreased serum hemoglobin and elevated serum amylase. Contrast-enhanced computed tomography revealed acute pancreatitis and formation of a pseudoaneurysm in the IPMN. We suspected rupture of a pseudoaneurysm and performed trans-catheter angiography. Angiography showed extravasation from the posterior superior pancreaticoduodenal artery, and coil embolization was performed. It is important to be alert for the formation of pseudoaneurysm in patients with cystic neoplasms.

    Download PDF (2596K)
  • Yoshinori Arai, Maiko Ogawa, Rikako Arimoto, Yoshitaka Ando, Daisuke E ...
    2021 Volume 60 Issue 13 Pages 2039-2046
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    Chronic idiopathic intestinal pseudo-obstruction (CIIP) caused by impaired intestinal peristalsis leads to intestinal obstructive symptoms. A 20-year-old man had marked esophageal dilatation that was found incidentally on chest radiography during a health examination. Chest/abdominal contrast-enhanced computed tomography and endoscopy showed marked esophageal and duodenal dilatation without mechanical obstruction. Upper gastrointestinal series and high-resolution esophageal manometry revealed absent peristalsis in the dilated part. CIIP was suspected in the patient's father, suggesting familial CIIP. The patient likely had signs of pre-onset CIIP. This is the first case of suspected CIIP in which detailed gastrointestinal tract examinations were performed before symptoms appeared.

    Download PDF (3496K)
  • Kenji Yamaoka, Tomokazu Kawaoka, Hiroshi Aikata, Yuwa Ando, Yumi Kosak ...
    2021 Volume 60 Issue 13 Pages 2047-2053
    Published: July 01, 2021
    Released: July 01, 2021
    JOURNAL OPEN ACCESS

    A 68-year-old man with hepatocellular carcinoma (HCC) visited his previous hospital due to abdominal pain and was diagnosed with ruptured HCC. Before visiting our hospital, he underwent HCC treatment at his previous hospital, but his tumors did not improve. Although he started treatment with sorafenib, the tumors rapidly grew. Subsequently, regorafenib was given, and the tumors shrank. After 22 months being treated with regorafenib, HCC reoccurred, with a new lung metastasis and a contrast-enhanced nodule on the peritoneal dissemination appearing. He underwent conversion surgery and survived for 4.5 years after his HCC was diagnosed.

    Download PDF (3236K)
  • Tatsuya Noguchi, Shomei Ryozawa, Masafumi Mizuide, Yuki Tanisaka, Akas ...
    2021 Volume 60 Issue 13 Pages 2055-2059
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    Abdominal ultrasonography in a 70-year-old woman showed a hypoechoic mass, 14 mm in diameter, in the pancreatic body. Computed tomography showed a mass with contrast effect in the pancreatic body. Test results for endocrine factors or tumor markers were normal. The initial consideration was nonfunctional pancreatic neuroendocrine tumor. Over 8 years of monitoring, the tumor diameter increased to 18 mm, until pancreatic tumor enucleation was performed. The postoperative diagnosis was pancreatic hamartoma, a rare type of benign pancreatic tumor. The preoperative diagnosis of pancreatic hamartoma is difficult, but consideration must be given to the possibility of hamartoma when encountering pancreatic tumors.

    Download PDF (1639K)
  • Mai Totsuka, Masayuki Honda, Tatsuo Kanda, Tomotaka Ishii, Naoki Matsu ...
    2021 Volume 60 Issue 13 Pages 2061-2066
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    A 74-year-old man with a history of transfusion at 35 years old in Egypt was referred to our hospital. He was infected with hepatitis C virus (HCV) genotype 4 (GT4), which is a rare HCV GT in Japan, and was also diagnosed with hepatic compensated cirrhosis. We safely treated the patient for 12 weeks with the combination of glecaprevir and pibrentasvir, and a sustained virologic response (SVR) was achieved. This is the first report of HCV GT4 infection in a treatment-naïve Japanese patient with cirrhosis in whom SVR was achieved with the combination treatment of glecaprevir and pibrentasvir.

    Download PDF (764K)
  • Yu Tanaka, Tetsuya Takikawa, Kiyoshi Kume, Kazuhiro Kikuta, Shin Hamad ...
    2021 Volume 60 Issue 13 Pages 2067-2074
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    A 71-year-old man underwent surgery for a pancreatic neuroendocrine tumor. Follow-up imaging showed swelling of the remnant pancreas, and he was histologically diagnosed with autoimmune pancreatitis based on endoscopic ultrasonography-guided fine-needle aspiration specimens. After two years, a tumor appeared on the liver surface. Although we planned to perform laparoscopic partial hepatectomy, the intraoperative findings showed that the tumor was located in the diaphragm. Partial resection of the diaphragm was performed, and the final diagnosis was an immunoglobulin G4-related inflammatory pseudotumor in the diaphragm. To our knowledge, this is the first reported case of an immunoglobulin G4-related diaphragmatic inflammatory pseudotumor.

    Download PDF (3328K)
  • Yoshihide Matsumoto, Kento Ogawa, Akiko Shimizu, Masaharu Nakamura, Sh ...
    2021 Volume 60 Issue 13 Pages 2075-2079
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    A 28-year-old woman was referred to our hospital for liver dysfunction and neck pain. Blood tests revealed elevated liver enzymes and eosinophilia. Ultrasonography, computed tomography, and magnetic resonance imaging showed a mass lesion near the hepatic hilus. The tumor was considered to be an inflammatory pseudo-tumor or malignancy. A liver-mass biopsy was performed and led to a diagnosis of inflammatory pseudo-tumor. In the present case, a markedly elevated eosinophil count was a characteristic clinical feature, and the patient underwent steroid therapy. Treatment resulted in a reduced eosinophil count, improved neck symptoms, and disappearance of the inflammatory pseudo-tumor.

    Download PDF (2635K)
  • Keisuke Nakabayashi, Manabu Murakami, Shinya Hata, Yuta Terabe, Nobuhi ...
    2021 Volume 60 Issue 13 Pages 2081-2084
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    An 80-year-old man was transferred to our institution with lower limb edema and worsening dyspnea following the administration of diuretic medication. Transthoracic echocardiography and computed tomography revealed a giant hepatic cyst (176×190 mm) compressing his right atrium and inferior vena cava (IVC). Laparoscopic cyst deroofing combined with omental packing and subsequent tube drainage immediately alleviated all his symptoms. The procedure was uneventful, and he was discharged without any complications on postoperative day 9; he had no recurrent symptoms or hepatic cysts at the postoperative 2-month follow-up. Therefore, a giant hepatic cyst can cause IVC syndrome, and laparoscopic deroofing is a beneficial approach for the treatment of accessible cysts.

    Download PDF (2318K)
  • Toranosuke Sekine, Masashi Kamioka, Naoko Hijioka, Shinya Yamada, Taka ...
    2021 Volume 60 Issue 13 Pages 2085-2088
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    We herein report a rare case of long QT syndrome (LQTS) coexisting with acetylcholine (Ach)-induced vasospasm. A 31-year-old woman experienced cardiopulmonary arrest during running. LQTS was diagnosed by an electrocardiogram, and the coexistence of Ach-induced vasospam was determined by an Ach provocation test on coronary angiography. Although an implantable cardioverter defibrillator was placed, a beta-blocker was not prescribed for two reasons: first, the patient showed Ach-induced vasospasm alone with no symptoms and no ST change by Ach injection, and second, the use of beta-blockers alone in such patients carries a risk of vasospasm-induced ventricular fibrillation.

    Download PDF (4080K)
  • Akio Chikata, Takeshi Kato, Kazuo Usuda, Shuhei Fujita, Kan-Ichi Otowa ...
    2021 Volume 60 Issue 13 Pages 2089-2092
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    We herein report a 60-year-old woman with long-standing persistent atrial fibrillation (AF) who developed QT prolongation and torsade de pointes (TdP) after pulmonary vein isolation (PVI). When electrical cardioversion was performed three months before PVI, prominent QT prolongation was not observed. QT prolongation emerged after PVI and was sustained until AF recurrence on the third day after ablation, and TdP disappeared along with AF recurrence. PVI affects the ganglionated plexi around the atrium, leading to modification of the intrinsic cardiac autonomic system. This case indicates that PVI has the potential risk of inducing lethal ventricular arrhythmias due to QT prolongation.

    Download PDF (2082K)
  • Teruhiko Imamura, Akira Oshima, Nikhil Narang, Ryuichi Ushijima, Yohei ...
    2021 Volume 60 Issue 13 Pages 2093-2095
    Published: July 01, 2021
    Released: July 01, 2021
    JOURNAL OPEN ACCESS

    Hyperkalemia is a challenging comorbidity to manage in patients with heart failure and chronic kidney disease, particularly when administering renin-angiotensin-aldosterone system inhibitors. We encountered an 88-year-old woman with hypertensive heart failure and chronic kidney disease. A mineralocorticoid receptor antagonist was able to be safely administered despite persistent hyperkalemia when sodium zirconium cyclosilicate, a non-absorbed, non-polymer zirconium silicate compound that preferentially exchanges hydrogen and sodium for potassium and ammonium ions in the gastrointestinal tract, was concomitantly administered. Sodium zirconium cyclosilicate might be a promising therapeutic tool to use in order to administer mineralocorticoid receptor antagonist safely in patients with heart failure, chronic kidney disease, and hyperkalemia.

    Download PDF (233K)
  • Yoshinori Mano, Akiyasu Baba, Hiroaki Sukegawa, Mitsuaki Sawano, Takaf ...
    2021 Volume 60 Issue 13 Pages 2097-2102
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    We herein report a 75-year-old woman who was diagnosed with Takotsubo syndrome (TTS) complicated by left ventricular outflow tract obstruction on admission. Treatment with beta-blocker and anticoagulant was started; however, her hemoglobin level decreased gradually, and computed tomography performed one week later revealed hemopericardium. Oozing-type cardiac rupture was suspected; therefore, we discontinued heparin treatment. Finally, she recovered uneventfully without cardiac surgery. It is noteworthy that cardiac rupture may occur with TTS, especially in patients treated with prophylactic anticoagulation therapy for apical thrombus. Furthermore, conservative, careful observation is an alternative approach in patients with oozing-type cardiac rupture associated with TTS.

    Download PDF (1733K)
  • Masayuki Hara, Tetsuro Kusaba, Kenshi Ono, Naoko Masuzawa, Itaru Nakam ...
    2021 Volume 60 Issue 13 Pages 2103-2107
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    Glomerulopathy with fibronectin deposits (GFND) is a rare hereditary kidney disease with autosomal dominant inheritance. A 21-year-old woman who had been diagnosed with GFND 10 years ago was admitted for investigation of a rapid decline in her renal function, hemolytic anemia, and cardiac dysfunction. A renal biopsy showed GFND accompanied by extraglomerular vascular lesions. Comprehensive treatments against hypertension and anemia improved the renal function. Although there have been few reports of vascular lesions in GFND, we suspect that endothelial hyperpermeability resulting from hypertension caused the fibronectin deposition and narrowing of the extraglomerular vascular lumens, thereby accelerating hypertension and inducing hemolytic anemia.

    Download PDF (899K)
  • Keiko Nunomiya, Sumito Inoue, Kento Sato, Akira Igarashi, Keiko Yamauc ...
    2021 Volume 60 Issue 13 Pages 2109-2113
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    A 72-year-old man diagnosed with stage 4 lung adenocarcinoma developed asymptomatic pneumatosis intestinalis while undergoing treatment with first-line chemotherapy, which included carboplatin, paclitaxel, and bevacizumab (BEV). He was treated conservatively. The pneumatosis recurred while the patient was undergoing treatment with the third-line chemotherapy, which included pemetrexed (PEM). His condition resolved after 4 weeks of supportive therapy. To our knowledge, this is the first case in which pneumatosis intestinalis was induced twice by two drugs in a patient with lung cancer. BEV and PEM are often administered to patients with lung cancer; thus, it should be noted that pneumatosis intestinalis may occur as an adverse event in patients treated with these drugs.

    Download PDF (2046K)
  • Kazuaki Teshima, Masaaki Kume, Rui Kondo, Kenichi Shibata, Ko Abe, Hir ...
    2021 Volume 60 Issue 13 Pages 2115-2118
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    A 17-year-old girl was diagnosed with acute lymphoblastic leukemia (ALL). After the administration of high-dose methotrexate (MTX) or intrathecal MTX, the patient experienced transient hemiparesis and motor aphasia. Diffusion-weighted magnetic resonance imaging showed a high-intensity lesion in the bilateral centrum semiovale, and a vasospasm was detected in the proximal segment of bilateral A1 on magnetic resonance angiography. Edaravone was administered, and leucovorin rescue treatment was continued; eventually, the patient's neurological symptoms completely resolved. This finding suggested that vasospasm might be a mechanism underlying MTX-induced transient encephalopathy in adolescent and young adult patients with ALL.

    Download PDF (314K)
  • Hiroki Hosoi, Toshiki Mushino, Kazutaka Nakashima, Kodai Kuriyama, Shi ...
    2021 Volume 60 Issue 13 Pages 2119-2123
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    A 30-year-old woman was diagnosed with T-lymphoblastic lymphoma (T-LBL) that harbored a clonal Epstein-Barr virus (EBV) genome. At relapse, axillary lymph node adenopathy, which was diagnosed as peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), was detected. Southern blot analyses of the T-cell receptor and EBV genome revealed that the T-LBL and PTCL-NOS were clonally identical. We previously showed that CD21 acted as an entry molecule that allowed EBV into the patient's T-LBL cells. Interestingly, the PTCL-NOS cells lacked CD21 expression. Our case suggests that EBV might infect immature CD21-positive T-cells, and CD21-negative PTCL-NOS might subsequently arise through phenotypic changes.

    Download PDF (819K)
  • Namiko Matsumoto, Nozomi Hishikawa, Ken Ikegami, Kota Sato, Yoshio Omo ...
    2021 Volume 60 Issue 13 Pages 2125-2128
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: December 29, 2020
    JOURNAL OPEN ACCESS

    We herein report a 75-year-old man who developed disturbed consciousness with polynuclear cell dominant pleocytosis and low glucose and extremely high interleukin (IL)-6 levels in his cerebrospinal fluid. The biopsy specimen from his right supraclavicular lymph node showed the infiltration of inflammatory cells positive for IgG, IgG4 and IL-6. Prednisolone and azathioprine administered under suspicion of IgG4-related disease (IgG4-RD) or multicentric Castleman's disease (MCD) successfully remitted the symptoms. However, he developed myelodysplastic syndrome (MDS) and died 18 months later. The extremely high IL-6 may have been related to the rare neurological manifestations and development of MDS in the present case.

    Download PDF (809K)
  • Satoshi Kanezawa, Wataru Narita, Kayoko Yokoi, Kouji Sasaki, Nozomu Mo ...
    2021 Volume 60 Issue 13 Pages 2129-2134
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 08, 2021
    JOURNAL OPEN ACCESS

    Conscious hemiasomatognosia is a disorder of the bodily self, involving subjective symptom where patients feel as if their whole body or part of one side has disappeared. Somatosensory disturbance is considered an essential component of conscious hemiasomatognosia. We herein report a 64-year-old man with conscious hemiasomatognosia of the right arm that developed after a left parietotemporal infarction, without any somatosensory disturbance except for a unique tactile localization problem. His response to the tactile localization test suggested impaired recognition of the positional relationship of his right arm relative to the entire body but normal recognition of positional relationships within the arm.

    Download PDF (1595K)
  • Komei Sakata, Jun Kikuchi, Katsura Emoto, Tomomi Kotaki, Yuichiro Ota, ...
    2021 Volume 60 Issue 13 Pages 2135-2143
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: February 01, 2021
    JOURNAL OPEN ACCESS

    We herein report a rare case of a 66-year-old man with refractory chylothorax. Although he had been treated with moderate doses of prednisolone (PSL) on suspicion of pleuritis with Sjögren syndrome, the pleural effusion expanded after the reduction of PSL. Further workup including histopathological examinations of pleura led to the diagnosis of IgG4-RD with bilateral chylothorax without any leakage from the thoracic duct. Combination therapy with high-dose PSL plus rituximab successfully decreased the pleural effusion. This is a very rare case of IgG4-related pleuritis with chylothorax and the first report of its successful treatment with rituximab.

    Download PDF (2156K)
  • Naoki Tanomogi, Toshinori Otani, Junko Araki, Ayumi Sugitani, Shingo I ...
    2021 Volume 60 Issue 13 Pages 2145-2148
    Published: July 01, 2021
    Released: July 01, 2021
    [Advance publication] Released: May 14, 2021
    JOURNAL OPEN ACCESS

    We herein report a fatal case of coronavirus disease 2019 (COVID-19) pneumonia with rapid progression of respiratory failure and lymphopenia. Excessive recruitment and sequestration of lymphocytes in the lung were suggested as the pathophysiology underlying COVID-19-associated lymphopenia. Interestingly, the autopsy in this case revealed lymphocytic infiltration in the lungs even at sites that appeared normal on autopsy imaging. These findings suggest that in COVID-19 cases with risk factors of severe exacerbation, early glucocorticoid administration should be considered, especially if lymphopenia is present, even if the imaging findings show only mild abnormalities.

    Download PDF (962K)
PICTURES IN CLINICAL MEDICINE
LETTERS TO THE EDITOR
ERRATUM
feedback
Top